RECODE Trademark

Trademark Overview


On Wednesday, January 18, 2006, a trademark application was filed for RECODE with the United States Patent and Trademark Office. The USPTO has given the RECODE trademark a serial number of 78793653. The federal status of this trademark filing is ABANDONED - INCOMPLETE RESPONSE as of Thursday, September 13, 2007. This trademark is owned by Ambrx, Inc.. The RECODE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of advancements in and improvements to technology for others in the field of protein engineering via site-specific incorporation of novel and chemically-unique amino acids on existing proteins; laboratory research in the area of advancements in protein-therapy pharmacological and pharmacodynamic performance in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; scientific research, namely, studies of protein-based technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy and molecular biology
recode

General Information


Serial Number78793653
Word MarkRECODE
Filing DateWednesday, January 18, 2006
Status600 - ABANDONED - INCOMPLETE RESPONSE
Status DateThursday, September 13, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDevelopment of advancements in and improvements to technology for others in the field of protein engineering via site-specific incorporation of novel and chemically-unique amino acids on existing proteins; laboratory research in the area of advancements in protein-therapy pharmacological and pharmacodynamic performance in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; scientific research, namely, studies of protein-based technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy and molecular biology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 24, 2006
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmbrx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events


Event DateEvent Description
Thursday, September 13, 2007ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Thursday, September 13, 2007ABANDONMENT - INCOMPLETE RESPONSE
Thursday, August 23, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 22, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 22, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 21, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 21, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 27, 2007FINAL REFUSAL E-MAILED
Tuesday, February 27, 2007FINAL REFUSAL WRITTEN
Friday, February 9, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 9, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 9, 2007ASSIGNED TO LIE
Wednesday, January 17, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 4, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 17, 2006NON-FINAL ACTION E-MAILED
Monday, July 17, 2006NON-FINAL ACTION WRITTEN
Friday, July 7, 2006ASSIGNED TO EXAMINER
Tuesday, January 24, 2006NEW APPLICATION ENTERED IN TRAM